GV has thrown its weight behind Monte Rosa Therapeutics, which is working on biotechnology to degrade disease-driving proteins that have hitherto been considered undruggable.

University of London-linked Monte Rosa Therapeutics is working on biotechnology to degrade disease-driving proteins that have hitherto been considered undruggable.

Creative Biosciences has collected $88m in fresh funding from a consortium of new and existing shareholders, though Kingmed Diagnostics and Tasly did not return.

Creative Biosciences has collected $88m in fresh funding, five years after being founded by a Sun Yat-Sen University professor.

Novo and Bristol Myers-Squibb formed part of a group of new and existing backers that provided cash to Galecto, based on research from the universities of Lund and Edinburgh.

A group of new and existing backers have provided cash to Galecto, based on research from the universities of Lund and Edinburgh.

Kinnevik has led the LeFrak-backed community housing service provider’s latest round, taking its overall funding in excess of $110m.

Twitter has returned to back the social media platform that provides services in 15 Indian languages, which pushed its total funding to about $264m.

The existing investor has chipped into the anti-fraud technology producer’s $36.3m round that lifted its overall funding to more than $60m.

Schneider Electric co-led EV charging services provider Star Charge's series A round with China International Capital Corporation's CICC Capital.